Evidence map›Paper›PMID 34806373›Full record

ArticleACS chemical biology2021

Antibacterial Discovery via Phenotypic DNA-Encoded Library Screening.

Wesley G Cochrane, Patrick R Fitzgerald, Brian M Paegel

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research.Angewandte Chemie (International ed. in English) · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Small-molecule discovery through DNA-encoded libraries.Nature reviews. Drug discovery · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Translating the Genome into Drugs.Accounts of chemical research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Wesley G CochraneDepartment of Pharmaceutical Sciences, University of California, Irvine, California 92697, United States.
Patrick R FitzgeraldSkaggs Doctoral Program in the Chemical and Biological Sciences, Scripps Research, La Jolla, California 92037, United States.ORCID 0000-0002-9324-2134
Brian M PaegelDepartment of Pharmaceutical Sciences, University of California, Irvine, California 92697, United States.ORCID 0000-0002-6531-6693
University of California, Irvine · USScripps Research Institute · US

Funding

Activity-Based DNA-Encoded Library TechnologyR35GM140890 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Brian M Paegel · 2021 to 2026
$2.2M
High-Throughput Droplet-Scale Functional Screening of DNA-Encoded Combinatorial LibrariesR01GM120491 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI PAEGEL, BRIAN M · 2017 to 2020
$1.4M
Microfluidic High-Throughput Droplet-Scale Screening of DNA-Encoded Compound Libraries for Activators of the Bacterial Target ClpPK25AI128000 · NIAID · SCRIPPS FLORIDA · PI PRICE, ALEXANDER K · 2017 to 2019
$233k
NIAID NIH HHS K25 AI128000NIGMS NIH HHS R01 GM120491NIGMS NIH HHS R35 GM140890
6 · The paper itself

Abstract

The global rise of multidrug resistant infections poses an imminent, existential threat. Numerous pipelines have failed to convert biochemically active molecules into bona fide antibacterials, owing to a lack of chemical material with antibacterial-like physical properties in high-throughput screening compound libraries. Here, we demonstrate scalable design and synthesis of an antibacterial-like solid-phase DNA-encoded library (DEL, 7488 members) and facile hit deconvolution from whole-cell

Indexed as

Anti-Bacterial AgentsDNAApoptosisBacillus subtilisCiprofloxacinDrug DiscoveryEscherichia coliGene LibraryHigh-Throughput Screening AssaysMolecular StructureNaphthyridinesPiperazineStructure-Activity RelationshipAnti-Bacterial AgentsCiprofloxacinDNAfluoronaphthyridoneNaphthyridinesPiperazine

Identifiers

PMID34806373
PMCPMC8688339
OpenAlexW3216094468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.